beta

CRME

Cardiome Pharma Corporation

Crme

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

05-15-2018 after market close 03-13-2018 after market close 11-14-2017 after market close 08-08-2017 after market close 05-15-2017 after market close
Actual EPS -0.24 -0.24 -0.2 -0.26 -0.2
Consensus EPS -0.22 -0.19 -0.16 -0.18 -0.15
Estimated EPS -0.22 -0.19 -0.16 -0.18 -0.15
Number of Estimates 2 4 4 4 4
EPS Surprise -$0.02 -$0.05 -$0.04 -$0.08 -$0.05

Stats

Summary

Cardiome Pharma Corp is a specialty pharmaceutical company. It is engaged in the development and commercialization of cardiovascular therapies that will improve the quality of life and health of patients suffering from heart disease.

Market Cap: 53 Million

Primary Exchange: NASDAQ Capital Market

Website: http://www.cardiome.com

Shares Outstanding: 34.6 Million

Float: 34.6 Million

Dividend: 0.0 (0.0%)

Beta: 0.588109

Sector: Healthcare

Industry: Biotechnology

Short Interest (Jan 12, 2018): 105 Thousand

Ethical Flags

Animal testing

Longest drawdown: 855 trading days

From: 2015-01-20 To: 2018-05-16

Lowest Point:

Cardiome Pharma's (CRME) CEO William Hunter on Q1 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-05-15 22:14:04:000

Cardiome Pharma Corporation (CRME) Q1 2018 Earnings Conference Call May 15, 2018, 04:30 PM ET Executives Justin Renz - CFO David Dean - Chief Business Development Officer William Hunter - President, CEO & Director Analysts Dewey Steadman - Canaccord Genuity Sean Lee -… read more...

Cardiome Pharma's (CRME) CEO William Hunter on Q1 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-05-15 22:14:04:000

Cardiome Pharma Corporation (CRME) Q1 2018 Earnings Conference Call May 15, 2018, 04:30 PM ET Executives Justin Renz - CFO David Dean - Chief Business Development Officer William Hunter - President, CEO & Director Analysts Dewey Steadman - Canaccord Genuity Sean Lee -… read more...

Cardiome Pharma's (CRME) CEO William Hunter on Q1 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-05-15 22:14:04:000

Cardiome Pharma Corporation (CRME) Q1 2018 Earnings Conference Call May 15, 2018, 04:30 PM ET Executives Justin Renz - CFO David Dean - Chief Business Development Officer William Hunter - President, CEO & Director Analysts Dewey Steadman - Canaccord Genuity Sean Lee -… read more...

Cardiome Pharma's (CRME) CEO William Hunter on Q1 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-05-15 22:14:04:000

Cardiome Pharma Corporation (CRME) Q1 2018 Earnings Conference Call May 15, 2018, 04:30 PM ET Executives Justin Renz - CFO David Dean - Chief Business Development Officer William Hunter - President, CEO & Director Analysts Dewey Steadman - Canaccord Genuity Sean Lee -… read more...

Cardiome Pharma's (CRME) CEO William Hunter on Q1 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-05-15 22:14:04:000

Cardiome Pharma Corporation (CRME) Q1 2018 Earnings Conference Call May 15, 2018, 04:30 PM ET Executives Justin Renz - CFO David Dean - Chief Business Development Officer William Hunter - President, CEO & Director Analysts Dewey Steadman - Canaccord Genuity Sean Lee -… read more...

Cardiome Pharma's (CRME) CEO William Hunter on Q1 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-05-15 22:14:04:000

Cardiome Pharma Corporation (CRME) Q1 2018 Earnings Conference Call May 15, 2018, 04:30 PM ET Executives Justin Renz - CFO David Dean - Chief Business Development Officer William Hunter - President, CEO & Director Analysts Dewey Steadman - Canaccord Genuity Sean Lee -… read more...

Cardiome Pharma's (CRME) CEO William Hunter on Q1 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-05-15 22:14:04:000

Cardiome Pharma Corporation (CRME) Q1 2018 Earnings Conference Call May 15, 2018, 04:30 PM ET Executives Justin Renz - CFO David Dean - Chief Business Development Officer William Hunter - President, CEO & Director Analysts Dewey Steadman - Canaccord Genuity Sean Lee -… read more...

Cardiome Pharma's (CRME) CEO William Hunter on Q1 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-05-15 22:14:04:000

Cardiome Pharma Corporation (CRME) Q1 2018 Earnings Conference Call May 15, 2018, 04:30 PM ET Executives Justin Renz - CFO David Dean - Chief Business Development Officer William Hunter - President, CEO & Director Analysts Dewey Steadman - Canaccord Genuity Sean Lee -… read more...

Cardiome Pharma's (CRME) CEO William Hunter on Q1 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-05-15 22:14:04:000

Cardiome Pharma Corporation (CRME) Q1 2018 Earnings Conference Call May 15, 2018, 04:30 PM ET Executives Justin Renz - CFO David Dean - Chief Business Development Officer William Hunter - President, CEO & Director Analysts Dewey Steadman - Canaccord Genuity Sean Lee -… read more...

Cardiome Pharma's (CRME) CEO William Hunter on Q1 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-05-15 22:14:04:000

Cardiome Pharma Corporation (CRME) Q1 2018 Earnings Conference Call May 15, 2018, 04:30 PM ET Executives Justin Renz - CFO David Dean - Chief Business Development Officer William Hunter - President, CEO & Director Analysts Dewey Steadman - Canaccord Genuity Sean Lee -… read more...

Cardiome Pharma's (CRME) CEO William Hunter on Q1 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-05-15 22:14:04:000

Cardiome Pharma Corporation (CRME) Q1 2018 Earnings Conference Call May 15, 2018, 04:30 PM ET Executives Justin Renz - CFO David Dean - Chief Business Development Officer William Hunter - President, CEO & Director Analysts Dewey Steadman - Canaccord Genuity Sean Lee -… read more...

Cardiome Pharma's (CRME) CEO William Hunter on Q1 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-05-15 22:14:04:000

Cardiome Pharma Corporation (CRME) Q1 2018 Earnings Conference Call May 15, 2018, 04:30 PM ET Executives Justin Renz - CFO David Dean - Chief Business Development Officer William Hunter - President, CEO & Director Analysts Dewey Steadman - Canaccord Genuity Sean Lee -… read more...

Cardiome Pharma's (CRME) CEO William Hunter on Q1 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-05-15 22:14:04:000

Cardiome Pharma Corporation (CRME) Q1 2018 Earnings Conference Call May 15, 2018, 04:30 PM ET Executives Justin Renz - CFO David Dean - Chief Business Development Officer William Hunter - President, CEO & Director Analysts Dewey Steadman - Canaccord Genuity Sean Lee -… read more...

Cardiome Pharma's (CRME) CEO William Hunter on Q1 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-05-15 22:14:04:000

Cardiome Pharma Corporation (CRME) Q1 2018 Earnings Conference Call May 15, 2018, 04:30 PM ET Executives Justin Renz - CFO David Dean - Chief Business Development Officer William Hunter - President, CEO & Director Analysts Dewey Steadman - Canaccord Genuity Sean Lee -… read more...

Cardiome Pharma misses by $0.16, beats on revenue

via: SeekingAlpha at 2018-05-15 16:18:52:000

Cardiome Pharma (NASDAQ: CRME ): Q1 EPS of -$0.24 misses by $0.16 . More news on: Cardiome Pharma Corporation, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Cardiome Pharma misses by $0.16, beats on revenue

via: SeekingAlpha at 2018-05-15 16:18:52:000

Cardiome Pharma (NASDAQ: CRME ): Q1 EPS of -$0.24 misses by $0.16 . More news on: Cardiome Pharma Corporation, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Cardiome Pharma misses by $0.16, beats on revenue

via: SeekingAlpha at 2018-05-15 16:18:52:000

Cardiome Pharma (NASDAQ: CRME ): Q1 EPS of -$0.24 misses by $0.16 . More news on: Cardiome Pharma Corporation, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Cardiome Pharma misses by $0.16, beats on revenue

via: SeekingAlpha at 2018-05-15 16:18:52:000

Cardiome Pharma (NASDAQ: CRME ): Q1 EPS of -$0.24 misses by $0.16 . More news on: Cardiome Pharma Corporation, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Cardiome Pharma misses by $0.16, beats on revenue

via: SeekingAlpha at 2018-05-15 16:18:52:000

Cardiome Pharma (NASDAQ: CRME ): Q1 EPS of -$0.24 misses by $0.16 . More news on: Cardiome Pharma Corporation, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Cardiome Pharma misses by $0.16, beats on revenue

via: SeekingAlpha at 2018-05-15 16:18:52:000

Cardiome Pharma (NASDAQ: CRME ): Q1 EPS of -$0.24 misses by $0.16 . More news on: Cardiome Pharma Corporation, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Cardiome Pharma misses by $0.16, beats on revenue

via: SeekingAlpha at 2018-05-15 16:18:52:000

Cardiome Pharma (NASDAQ: CRME ): Q1 EPS of -$0.24 misses by $0.16 . More news on: Cardiome Pharma Corporation, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Cardiome Pharma misses by $0.16, beats on revenue

via: SeekingAlpha at 2018-05-15 16:18:52:000

Cardiome Pharma (NASDAQ: CRME ): Q1 EPS of -$0.24 misses by $0.16 . More news on: Cardiome Pharma Corporation, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Correvio Reports First Quarter 2018 Financial Results

via: PR Newswire at 2018-05-15 16:00:00:000

Management to Host Conference Call and Webcast Today, May 15, 2018 at 4:30 p.m. Eastern ( 1:30 p.m. Pacific) NASDAQ: CRME TSX: COM VANCOUVER , May 15, 2018 /PRNewswire/ -Correvio Pharma Corp. (NASDAQ: CRME / TSX: COM), formerly Cardiome Pharma Corp., a revenue-gene… read more...

Correvio Reports First Quarter 2018 Financial Results

via: PR Newswire at 2018-05-15 16:00:00:000

Management to Host Conference Call and Webcast Today, May 15, 2018 at 4:30 p.m. Eastern ( 1:30 p.m. Pacific) NASDAQ: CRME TSX: COM VANCOUVER , May 15, 2018 /PRNewswire/ -Correvio Pharma Corp. (NASDAQ: CRME / TSX: COM), formerly Cardiome Pharma Corp., a revenue-gene… read more...

Correvio Reports First Quarter 2018 Financial Results

via: PR Newswire at 2018-05-15 16:00:00:000

Management to Host Conference Call and Webcast Today, May 15, 2018 at 4:30 p.m. Eastern ( 1:30 p.m. Pacific) NASDAQ: CRME TSX: COM VANCOUVER , May 15, 2018 /PRNewswire/ -Correvio Pharma Corp. (NASDAQ: CRME / TSX: COM), formerly Cardiome Pharma Corp., a revenue-gene… read more...

Correvio Reports First Quarter 2018 Financial Results

via: PR Newswire at 2018-05-15 16:00:00:000

Management to Host Conference Call and Webcast Today, May 15, 2018 at 4:30 p.m. Eastern ( 1:30 p.m. Pacific) NASDAQ: CRME TSX: COM VANCOUVER , May 15, 2018 /PRNewswire/ -Correvio Pharma Corp. (NASDAQ: CRME / TSX: COM), formerly Cardiome Pharma Corp., a revenue-gene… read more...

Correvio Reports First Quarter 2018 Financial Results

via: PR Newswire at 2018-05-15 16:00:00:000

Management to Host Conference Call and Webcast Today, May 15, 2018 at 4:30 p.m. Eastern ( 1:30 p.m. Pacific) NASDAQ: CRME TSX: COM VANCOUVER , May 15, 2018 /PRNewswire/ -Correvio Pharma Corp. (NASDAQ: CRME / TSX: COM), formerly Cardiome Pharma Corp., a revenue-gene… read more...

Correvio Reports First Quarter 2018 Financial Results

via: PR Newswire at 2018-05-15 16:00:00:000

Management to Host Conference Call and Webcast Today, May 15, 2018 at 4:30 p.m. Eastern ( 1:30 p.m. Pacific) NASDAQ: CRME TSX: COM VANCOUVER , May 15, 2018 /PRNewswire/ -Correvio Pharma Corp. (NASDAQ: CRME / TSX: COM), formerly Cardiome Pharma Corp., a revenue-gene… read more...

Correvio Reports First Quarter 2018 Financial Results

via: PR Newswire at 2018-05-15 16:00:00:000

Management to Host Conference Call and Webcast Today, May 15, 2018 at 4:30 p.m. Eastern ( 1:30 p.m. Pacific) NASDAQ: CRME TSX: COM VANCOUVER , May 15, 2018 /PRNewswire/ -Correvio Pharma Corp. (NASDAQ: CRME / TSX: COM), formerly Cardiome Pharma Corp., a revenue-gene… read more...

Correvio Reports First Quarter 2018 Financial Results

via: PR Newswire at 2018-05-15 16:00:00:000

Management to Host Conference Call and Webcast Today, May 15, 2018 at 4:30 p.m. Eastern ( 1:30 p.m. Pacific) NASDAQ: CRME TSX: COM VANCOUVER , May 15, 2018 /PRNewswire/ -Correvio Pharma Corp. (NASDAQ: CRME / TSX: COM), formerly Cardiome Pharma Corp., a revenue-gene… read more...

Correvio Pharma Corp Completes Strategic Transaction with Cipher Pharmaceuticals

via: PR Newswire at 2018-05-15 08:40:00:000

NASDAQ: CRME TSX: COM Cardiome Pharma Corp. Becomes Correvio Pharma Corp., Closes on $25.5 million (CAD) in Non-Dilutive Capital VANCOUVER , May 15, 2018 /PRNewswire/ -Correvio Pharma Corp. ("Correvio"), formerly Cardiome Pharma Corp. ("Cardiome") (NASDAQ:CRME … read more...

Correvio Pharma Corp Completes Strategic Transaction with Cipher Pharmaceuticals

via: PR Newswire at 2018-05-15 08:40:00:000

NASDAQ: CRME TSX: COM Cardiome Pharma Corp. Becomes Correvio Pharma Corp., Closes on $25.5 million (CAD) in Non-Dilutive Capital VANCOUVER , May 15, 2018 /PRNewswire/ -Correvio Pharma Corp. ("Correvio"), formerly Cardiome Pharma Corp. ("Cardiome") (NASDAQ:CRME … read more...

Correvio Pharma Corp Completes Strategic Transaction with Cipher Pharmaceuticals

via: PR Newswire at 2018-05-15 08:40:00:000

NASDAQ: CRME TSX: COM Cardiome Pharma Corp. Becomes Correvio Pharma Corp., Closes on $25.5 million (CAD) in Non-Dilutive Capital VANCOUVER , May 15, 2018 /PRNewswire/ -Correvio Pharma Corp. ("Correvio"), formerly Cardiome Pharma Corp. ("Cardiome") (NASDAQ:CRME … read more...

Correvio Pharma Corp Completes Strategic Transaction with Cipher Pharmaceuticals

via: PR Newswire at 2018-05-15 08:40:00:000

NASDAQ: CRME TSX: COM Cardiome Pharma Corp. Becomes Correvio Pharma Corp., Closes on $25.5 million (CAD) in Non-Dilutive Capital VANCOUVER , May 15, 2018 /PRNewswire/ -Correvio Pharma Corp. ("Correvio"), formerly Cardiome Pharma Corp. ("Cardiome") (NASDAQ:CRME … read more...

Correvio Pharma Corp Completes Strategic Transaction with Cipher Pharmaceuticals

via: PR Newswire at 2018-05-15 08:40:00:000

NASDAQ: CRME TSX: COM Cardiome Pharma Corp. Becomes Correvio Pharma Corp., Closes on $25.5 million (CAD) in Non-Dilutive Capital VANCOUVER , May 15, 2018 /PRNewswire/ -Correvio Pharma Corp. ("Correvio"), formerly Cardiome Pharma Corp. ("Cardiome") (NASDAQ:CRME … read more...

Correvio Pharma Corp Completes Strategic Transaction with Cipher Pharmaceuticals

via: PR Newswire at 2018-05-15 08:40:00:000

NASDAQ: CRME TSX: COM Cardiome Pharma Corp. Becomes Correvio Pharma Corp., Closes on $25.5 million (CAD) in Non-Dilutive Capital VANCOUVER , May 15, 2018 /PRNewswire/ -Correvio Pharma Corp. ("Correvio"), formerly Cardiome Pharma Corp. ("Cardiome") (NASDAQ:CRME … read more...

Correvio Pharma Corp Completes Strategic Transaction with Cipher Pharmaceuticals

via: PR Newswire at 2018-05-15 08:40:00:000

NASDAQ: CRME TSX: COM Cardiome Pharma Corp. Becomes Correvio Pharma Corp., Closes on $25.5 million (CAD) in Non-Dilutive Capital VANCOUVER , May 15, 2018 /PRNewswire/ -Correvio Pharma Corp. ("Correvio"), formerly Cardiome Pharma Corp. ("Cardiome") (NASDAQ:CRME … read more...

Correvio Pharma Corp Completes Strategic Transaction with Cipher Pharmaceuticals

via: PR Newswire at 2018-05-15 08:40:00:000

NASDAQ: CRME TSX: COM Cardiome Pharma Corp. Becomes Correvio Pharma Corp., Closes on $25.5 million (CAD) in Non-Dilutive Capital VANCOUVER , May 15, 2018 /PRNewswire/ -Correvio Pharma Corp. ("Correvio"), formerly Cardiome Pharma Corp. ("Cardiome") (NASDAQ:CRME … read more...

Cardiome Announces Results From Annual and Special Meeting of Shareholders and Timing For First Quarter 2018 Financial Results Conference Call

via: PR Newswire at 2018-05-10 07:00:00:000

Shareholders Approve Cipher Acquisition of Canadian Business Portfolio of Cardiome Company to Host First Quarter 2018 Financial Results Conference Call on Tuesday, May 15, 2018 at 4:30 p.m. ET NASDAQ: CRME TSX: COM VANCOUVER , May 10, 2018 /PRNewswire/ - Cardiome Pharma C… read more...

Cardiome Announces Results From Annual and Special Meeting of Shareholders and Timing For First Quarter 2018 Financial Results Conference Call

via: PR Newswire at 2018-05-10 07:00:00:000

Shareholders Approve Cipher Acquisition of Canadian Business Portfolio of Cardiome Company to Host First Quarter 2018 Financial Results Conference Call on Tuesday, May 15, 2018 at 4:30 p.m. ET NASDAQ: CRME TSX: COM VANCOUVER , May 10, 2018 /PRNewswire/ - Cardiome Pharma C… read more...

Cardiome Announces Results From Annual and Special Meeting of Shareholders and Timing For First Quarter 2018 Financial Results Conference Call

via: PR Newswire at 2018-05-10 07:00:00:000

Shareholders Approve Cipher Acquisition of Canadian Business Portfolio of Cardiome Company to Host First Quarter 2018 Financial Results Conference Call on Tuesday, May 15, 2018 at 4:30 p.m. ET NASDAQ: CRME TSX: COM VANCOUVER , May 10, 2018 /PRNewswire/ - Cardiome Pharma C… read more...

Cardiome Announces Results From Annual and Special Meeting of Shareholders and Timing For First Quarter 2018 Financial Results Conference Call

via: PR Newswire at 2018-05-10 07:00:00:000

Shareholders Approve Cipher Acquisition of Canadian Business Portfolio of Cardiome Company to Host First Quarter 2018 Financial Results Conference Call on Tuesday, May 15, 2018 at 4:30 p.m. ET NASDAQ: CRME TSX: COM VANCOUVER , May 10, 2018 /PRNewswire/ - Cardiome Pharma C… read more...

Cardiome Announces Results From Annual and Special Meeting of Shareholders and Timing For First Quarter 2018 Financial Results Conference Call

via: PR Newswire at 2018-05-10 07:00:00:000

Shareholders Approve Cipher Acquisition of Canadian Business Portfolio of Cardiome Company to Host First Quarter 2018 Financial Results Conference Call on Tuesday, May 15, 2018 at 4:30 p.m. ET NASDAQ: CRME TSX: COM VANCOUVER , May 10, 2018 /PRNewswire/ - Cardiome Pharma C… read more...

Cardiome Announces Results From Annual and Special Meeting of Shareholders and Timing For First Quarter 2018 Financial Results Conference Call

via: PR Newswire at 2018-05-10 07:00:00:000

Shareholders Approve Cipher Acquisition of Canadian Business Portfolio of Cardiome Company to Host First Quarter 2018 Financial Results Conference Call on Tuesday, May 15, 2018 at 4:30 p.m. ET NASDAQ: CRME TSX: COM VANCOUVER , May 10, 2018 /PRNewswire/ - Cardiome Pharma C… read more...

Cardiome up 13% premarket on United Therapeutics' takeout of SteadyMed

via: SeekingAlpha at 2018-04-30 09:10:53:000

Thinly traded nano cap Cardiome (NASDAQ: CRME ) is up 13% premarket on light volume on the heels of United Therapeutics' planned acquisition of SteadyMed that includes a contingent amount of $75M based on the commercialization of drug-device Trevyent. More news on: Cardiome Pha… read more...

Cardiome up 13% premarket on United Therapeutics' takeout of SteadyMed

via: SeekingAlpha at 2018-04-30 09:10:53:000

Thinly traded nano cap Cardiome (NASDAQ: CRME ) is up 13% premarket on light volume on the heels of United Therapeutics' planned acquisition of SteadyMed that includes a contingent amount of $75M based on the commercialization of drug-device Trevyent. More news on: Cardiome Pha… read more...

Cardiome up 13% premarket on United Therapeutics' takeout of SteadyMed

via: SeekingAlpha at 2018-04-30 09:10:53:000

Thinly traded nano cap Cardiome (NASDAQ: CRME ) is up 13% premarket on light volume on the heels of United Therapeutics' planned acquisition of SteadyMed that includes a contingent amount of $75M based on the commercialization of drug-device Trevyent. More news on: Cardiome Pha… read more...

Cardiome up 13% premarket on United Therapeutics' takeout of SteadyMed

via: SeekingAlpha at 2018-04-30 09:10:53:000

Thinly traded nano cap Cardiome (NASDAQ: CRME ) is up 13% premarket on light volume on the heels of United Therapeutics' planned acquisition of SteadyMed that includes a contingent amount of $75M based on the commercialization of drug-device Trevyent. More news on: Cardiome Pha… read more...

Cardiome to Present at the Bloom Burton & Co. Healthcare Investor Conference

via: PR Newswire at 2018-04-26 16:33:00:000

NASDAQ:CRME, TSX:COM VANCOUVER , April 26, 2018 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ:CRME / TSX:COM), a revenue-generating, specialty pharmaceutical company focused on commercializing hospital drugs, today announced that Mr. David Dean , Chief Business Development Officer of … read more...

Cardiome to Present at the Bloom Burton & Co. Healthcare Investor Conference

via: PR Newswire at 2018-04-26 16:33:00:000

NASDAQ:CRME, TSX:COM VANCOUVER , April 26, 2018 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ:CRME / TSX:COM), a revenue-generating, specialty pharmaceutical company focused on commercializing hospital drugs, today announced that Mr. David Dean , Chief Business Development Officer of … read more...

Cardiome to Present at the Bloom Burton & Co. Healthcare Investor Conference

via: PR Newswire at 2018-04-26 16:33:00:000

NASDAQ:CRME, TSX:COM VANCOUVER , April 26, 2018 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ:CRME / TSX:COM), a revenue-generating, specialty pharmaceutical company focused on commercializing hospital drugs, today announced that Mr. David Dean , Chief Business Development Officer of … read more...

Cardiome to Present at the Bloom Burton & Co. Healthcare Investor Conference

via: PR Newswire at 2018-04-26 16:33:00:000

NASDAQ:CRME, TSX:COM VANCOUVER , April 26, 2018 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ:CRME / TSX:COM), a revenue-generating, specialty pharmaceutical company focused on commercializing hospital drugs, today announced that Mr. David Dean , Chief Business Development Officer of … read more...

Cardiome Completes Enrollment in the Post Approval Safety Study SPECTRUM Evaluating Brinavess®

via: PR Newswire at 2018-04-17 08:00:00:000

NASDAQ: CRME TSX: COM VANCOUVER , April 17, 2018 /PRNewswire/ -Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM), a revenue-generating, specialty pharmaceutical company focused on commercializing hospital drugs,today announced completion of enrollment for the Pha… read more...

Cardiome Completes Enrollment in the Post Approval Safety Study SPECTRUM Evaluating Brinavess®

via: PR Newswire at 2018-04-17 08:00:00:000

NASDAQ: CRME TSX: COM VANCOUVER , April 17, 2018 /PRNewswire/ -Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM), a revenue-generating, specialty pharmaceutical company focused on commercializing hospital drugs,today announced completion of enrollment for the Pha… read more...

Cardiome Completes Enrollment in the Post Approval Safety Study SPECTRUM Evaluating Brinavess®

via: PR Newswire at 2018-04-17 08:00:00:000

NASDAQ: CRME TSX: COM VANCOUVER , April 17, 2018 /PRNewswire/ -Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM), a revenue-generating, specialty pharmaceutical company focused on commercializing hospital drugs,today announced completion of enrollment for the Pha… read more...

Cardiome Completes Enrollment in the Post Approval Safety Study SPECTRUM Evaluating Brinavess®

via: PR Newswire at 2018-04-17 08:00:00:000

NASDAQ: CRME TSX: COM VANCOUVER , April 17, 2018 /PRNewswire/ -Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM), a revenue-generating, specialty pharmaceutical company focused on commercializing hospital drugs,today announced completion of enrollment for the Pha… read more...

Key events next week - healthcare

via: SeekingAlpha at 2018-04-13 09:56:25:000

Noteworthy events during the week of April 15 - 21 for healthcare investors. More news on: Bristol-Myers Squibb Company, Biondvax Pharmaceuticals, Rigel Pharmaceuticals, Inc., Healthcare stocks news, , Read more … read more...

Key events next week - healthcare

via: SeekingAlpha at 2018-04-13 09:56:25:000

Noteworthy events during the week of April 15 - 21 for healthcare investors. More news on: Bristol-Myers Squibb Company, Biondvax Pharmaceuticals, Rigel Pharmaceuticals, Inc., Healthcare stocks news, , Read more … read more...

Key events next week - healthcare

via: SeekingAlpha at 2018-04-13 09:56:25:000

Noteworthy events during the week of April 15 - 21 for healthcare investors. More news on: Bristol-Myers Squibb Company, Biondvax Pharmaceuticals, Rigel Pharmaceuticals, Inc., Healthcare stocks news, , Read more … read more...

Key events next week - healthcare

via: SeekingAlpha at 2018-04-13 09:56:25:000

Noteworthy events during the week of April 15 - 21 for healthcare investors. More news on: Bristol-Myers Squibb Company, Biondvax Pharmaceuticals, Rigel Pharmaceuticals, Inc., Healthcare stocks news, , Read more … read more...

Cardiome Announces Fifteen Xydalba(TM) and Zevtera® Abstracts at ECCMID 2018

via: PR Newswire at 2018-04-12 07:00:00:000

NASDAQ: CRME TSX: COM Company Will Also Host Xydalba Expert Educational Session Featuring Key Opinion Leaders in the Field of Hospital Anti-Infectives VANCOUVER , April 12, 2018 /PRNewswire/ -Cardiome Pharma Corp. (NASDAQ:CRME / TSX:COM), a revenue-generating, … read more...

Cardiome Announces Fifteen Xydalba(TM) and Zevtera® Abstracts at ECCMID 2018

via: PR Newswire at 2018-04-12 07:00:00:000

NASDAQ: CRME TSX: COM Company Will Also Host Xydalba Expert Educational Session Featuring Key Opinion Leaders in the Field of Hospital Anti-Infectives VANCOUVER , April 12, 2018 /PRNewswire/ -Cardiome Pharma Corp. (NASDAQ:CRME / TSX:COM), a revenue-generating, … read more...

Cardiome Announces Fifteen Xydalba(TM) and Zevtera® Abstracts at ECCMID 2018

via: PR Newswire at 2018-04-12 07:00:00:000

NASDAQ: CRME TSX: COM Company Will Also Host Xydalba Expert Educational Session Featuring Key Opinion Leaders in the Field of Hospital Anti-Infectives VANCOUVER , April 12, 2018 /PRNewswire/ -Cardiome Pharma Corp. (NASDAQ:CRME / TSX:COM), a revenue-generating, … read more...

Cardiome Announces Fifteen Xydalba(TM) and Zevtera® Abstracts at ECCMID 2018

via: PR Newswire at 2018-04-12 07:00:00:000

NASDAQ: CRME TSX: COM Company Will Also Host Xydalba Expert Educational Session Featuring Key Opinion Leaders in the Field of Hospital Anti-Infectives VANCOUVER , April 12, 2018 /PRNewswire/ -Cardiome Pharma Corp. (NASDAQ:CRME / TSX:COM), a revenue-generating, … read more...

Key healthcare events next week (continued)

via: SeekingAlpha at 2018-02-09 12:37:01:000

Additional presenters at Leerink's Global Healthcare Conference in New York, February 14 - 15: More news on: Epizyme, Intra-Cellular Therapies Inc., Tocagen Inc, Healthcare stocks news, Read more … read more...

Key healthcare events next week (continued)

via: SeekingAlpha at 2018-02-09 12:37:01:000

Additional presenters at Leerink's Global Healthcare Conference in New York, February 14 - 15: More news on: Epizyme, Intra-Cellular Therapies Inc., Tocagen Inc, Healthcare stocks news, Read more … read more...

Key healthcare events next week (continued)

via: SeekingAlpha at 2018-02-09 12:37:01:000

Additional presenters at Leerink's Global Healthcare Conference in New York, February 14 - 15: More news on: Epizyme, Intra-Cellular Therapies Inc., Tocagen Inc, Healthcare stocks news, Read more … read more...

Key healthcare events next week (continued)

via: SeekingAlpha at 2018-02-09 12:37:01:000

Additional presenters at Leerink's Global Healthcare Conference in New York, February 14 - 15: More news on: Epizyme, Intra-Cellular Therapies Inc., Tocagen Inc, Healthcare stocks news, Read more … read more...

Key healthcare events next week (continued)

via: SeekingAlpha at 2018-02-09 12:37:01:000

Additional presenters at Leerink's Global Healthcare Conference in New York, February 14 - 15: More news on: Epizyme, Intra-Cellular Therapies Inc., Tocagen Inc, Healthcare stocks news, Read more … read more...

Cardiome to Present at the Leerink Partners 7th Annual Global Healthcare Conference

via: PR Newswire at 2018-02-08 08:00:00:000

NASDAQ:CRME TSX:COM VANCOUVER , Feb. 8, 2018 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ:CRME / TSX:COM), a revenue-generating, specialty pharmaceutical company focused on commercializing patent-protected hospital drugs, today announced that Dr. Bill Hunter , President … read more...

Cardiome to Present at the Leerink Partners 7th Annual Global Healthcare Conference

via: PR Newswire at 2018-02-08 08:00:00:000

NASDAQ:CRME TSX:COM VANCOUVER , Feb. 8, 2018 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ:CRME / TSX:COM), a revenue-generating, specialty pharmaceutical company focused on commercializing patent-protected hospital drugs, today announced that Dr. Bill Hunter , President … read more...

Cardiome to Present at the Leerink Partners 7th Annual Global Healthcare Conference

via: PR Newswire at 2018-02-08 08:00:00:000

NASDAQ:CRME TSX:COM VANCOUVER , Feb. 8, 2018 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ:CRME / TSX:COM), a revenue-generating, specialty pharmaceutical company focused on commercializing patent-protected hospital drugs, today announced that Dr. Bill Hunter , President … read more...

Cardiome to Present at the Leerink Partners 7th Annual Global Healthcare Conference

via: PR Newswire at 2018-02-08 08:00:00:000

NASDAQ:CRME TSX:COM VANCOUVER , Feb. 8, 2018 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ:CRME / TSX:COM), a revenue-generating, specialty pharmaceutical company focused on commercializing patent-protected hospital drugs, today announced that Dr. Bill Hunter , President … read more...

Cardiome to Present at the Leerink Partners 7th Annual Global Healthcare Conference

via: PR Newswire at 2018-02-08 08:00:00:000

NASDAQ:CRME TSX:COM VANCOUVER , Feb. 8, 2018 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ:CRME / TSX:COM), a revenue-generating, specialty pharmaceutical company focused on commercializing patent-protected hospital drugs, today announced that Dr. Bill Hunter , President … read more...

Cardiome Announces Expanded Label for Aggrastat® in China Including New STEMI Indication and High Dose Bolus Regimen

via: PR Newswire at 2018-01-23 08:00:00:000

Addition of High-Risk STEMI Patients Significantly Expands the Number of Patients in Which Aggrastat Can Be Used NASDAQ:CRME TSX:COM VANCOUVER , Jan. 23, 2018 /PRNewswire/ -Cardiome Pharma Corp. (NASDAQ:CRME / TSX:COM), a revenue-generating, specialty pharmaceutical co… read more...

Cardiome to Participate in the Cantor Fitzgerald Antibiotics Summit

via: PR Newswire at 2018-01-10 08:00:00:000

NASDAQ:CRME TSX:COM VANCOUVER , Jan. 10, 2018 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ:CRME / TSX:COM), a revenue-generating, specialty pharmaceutical company focused on commercializing patent-protected hospital drugs, today announced that Mr. Justin Renz , Chief Financial Office… read more...

Your Daily Pharma Scoop: Ultragenyx Sells Voucher, Regeneron Announces Collaboration, Madrigal Offering

via: SeekingAlpha at 2017-12-19 08:04:09:000

Content Analysis of coverage: RARE Stocks in the news: REGN, MDGL Analyst Ratings Insider Sales Insider Purchases Earnings Report Secondary Offerings Earnings Calendar Subscriber Questions & Answers (for TPT Subscribers only) Catalyst Rundown (for… read more...

Cardiome Announces Strategic Licensing Agreement To Commercialize Aggrastat In Russia

via: PR Newswire at 2017-12-12 08:00:00:000

NASDAQ:CRMETSX:COM VANCOUVER , Dec.12, 2017 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ:CRME / TSX:COM), a revenue-generating, specialty pharmaceutical company focused on commercializing patent-protected hospital drugs, today announced that its affiliate Correvio has entere… read more...

Cardiome Highlights Partner SteadyMed's Agreement With FDA On Pathway To Trevyent NDA Resubmission

via: PR Newswire at 2017-12-11 08:00:00:000

NDA Expected to be Filed and Accepted by the End of 2018 NASDAQ:CRME TSX:COM VANCOUVER , Dec. 11, 2017 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ:CRME / TSX:COM), a revenue-generating, specialty pharmaceutical company focused on commercializing hospital drugs, today highlighted… read more...

Cardiome Announces Xydalba(TM) Treatment And Patient Experience Presentations At The 2017 National Opat Conference

via: PR Newswire at 2017-12-11 06:00:00:000

NASDAQ:CRMETSX:COM Plenary Symposium Features Three Experts Discussing Clinical Use VANCOUVER , Dec.11, 2017 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ:CRME / TSX:COM), a revenue-generating, specialty pharmaceutical company focused on commercializing patent-protected … read more...

Cardiome to Present at the 29th Annual Piper Jaffray Healthcare Conference

via: PR Newswire at 2017-11-20 08:00:00:000

NASDAQ: CRME TSX: COM VANCOUVER , Nov. 20, 2017 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM), a revenue-generating, specialty pharmaceutical company focused on commercializing patent-protected hospital drugs, today announced that Mr. Justin Renz , Chief Financial Of… read more...

Cardiome Pharma's (CRME) CEO William Hunter on Q3 2017 Results - Earnings Call Transcript

via: SeekingAlpha at 2017-11-14 23:21:12:000

Cardiome Pharma Corporation (CRME) Q3 2017 Results Earnings Conference Call November 14, 2017, 04:30 PM ET Executives William Hunter - President and Chief Executive Officer David Dean - Chief Business Development Officer Justin Renz - Chief Financial Officer Analysts David … read more...

Cardiome Pharma misses by $0.02, misses on revenue

via: SeekingAlpha at 2017-11-14 16:08:15:000

Cardiome Pharma (NASDAQ: CRME ): Q3 EPS of -$0.20 misses by $0.02 . Revenue of $6.02M (+16.0% Y/Y) misses by $1.4M . Press Release More news on: Cardiome Pharma Corporation, Earnings news and commentary, Healthcare stocks news, , read more...

Cardiome Reports Third Quarter 2017 Financial Results

via: PR Newswire at 2017-11-14 16:01:00:000

NASDAQ: CRME TSX: COM Management to Host Conference Call and Webcast Today, November 14, 2017 at 4:30 p.m. ET ( 1:30 p.m. PT ) VANCOUVER , Nov. 14, 2017 /PRNewswire/ -Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM), a revenue-generating, specialty pharmaceutical company f… read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
2013-04-12 5.0 1.0 5.0
Data provided for free by IEX